OBJECTIVE: Thymus is an immune organ in which pathological changes may cause
autoimmune diseases, including myasthenia gravis (MG). Recent studies have focused on …

An imbalance in Th17 cells and Tregs may be an important cause of the pathogenesis of
thymoma with myasthenia gravis (MG). In this study, 30 patients with simple thymoma and …

Myasthenia gravis (MG) is an immune-mediated disease frequently associated with thymic
changes. Increased T helper 17 (Th17) cell activity and dysfunctional regulatory T (Treg) …

Imbalance of T helper 17 (Th17)/regulatory T (Treg) cells is involved in the pathogenesis of
myasthenia gravis with thymoma (MG‐T). Long non‐coding RNAs (lncRNAs) are implicated …

The thymus is the main site of immune sensitization to AChR in myasthenia gravis (MG). In
our previous studies we demonstrated that Toll-like receptor (TLR) 4 is over-expressed in …

Thymic abnormalities are present in∼ 80% of myasthenia gravis (MG) patients, and the
thymus seems to be the main site of autosensitization to the acetylcholine receptor. In view …

Myasthenia gravis (MG) is a prototypical CD4+ T cell–dependent autoimmune disease
mediated by anti‐acetylcholine receptor autoantibodies (AChR‐Abs). Certain subsets of …

Objective To investigate the immunoregulatory role of Th17 cell and the related cytokines in
myasthenia gravis. Methods Totally 51 myasthenia gravis (MG) patients were divided into …

OBJECTIVE: To investigate the expression of both thymic regulatory T cells (CD4+ CD25+
Foxp3+ cells, Treg) and thymic stromal lymphopoietin (TSLP) in thymomas accompanying …

Objective: Myasthenia gravis (MG) is an autoimmune disease mediated by autoantibodies
against the neuromuscular junction. The thymus has an important role in the pathogenesis …